GO
Loading...

Edwards Lifesciences Corp

More

  • *Amazon tumbles, Microsoft climbs after earnings. NEW YORK, Oct 24- U.S. stocks advanced on Friday, as earnings from Microsoft and Procter& Gamble coupled with easing concerns over the possible spread of Ebola in the United States helped put the S&P on track to snap a four-week losing skid. Microsoft was up 1.7 percent at $45.91, after it reported...

  • *Amazon tumbles, Microsoft climbs after earnings. NEW YORK, Oct 24- U.S. stocks advanced on Friday, as earnings from Microsoft and Procter& Gamble and easing concerns over the possible spread of Ebola in the United States helped put the S&P on track to snap a four-week losing skid. Microsoft was up 2 percent at $45.91, after it reported higher-than-expected...

  • *Amazon tumbles, Microsoft climbs after earnings. NEW YORK, Oct 24- U.S. stocks advanced on Friday, buoyed by gains in Microsoft and Procter& Gamble after their quarterly results and as steps towards expediting the development of vaccines for Ebola eased concerns over its possible spread in the United States. Microsoft was up 1.6 percent at $45.75, after it...

  • Edwards Lifesciences beats Street 3Q forecasts Thursday, 23 Oct 2014 | 4:39 PM ET

    IRVINE, Calif. _ Edwards Lifesciences Corp. on Thursday reported third-quarter earnings of $94.6 million. For the current quarter ending in December, Edwards Lifesciences expects its per-share earnings to range from 89 cents to 95 cents. Edwards Lifesciences expects full-year earnings in the range of $3.33 to $3.39 per share, with revenue ranging from $2.05...

  • Aug 19- Medtronic Inc Chief Executive Omar Ishrak defended his company's plan to acquire Dublin- based Covidien Plc in a so-called inversion deal, saying the medical device maker will be able to create more U.S. jobs while still paying substantial taxes once the transaction closes.

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • Stocks rise for third day with Fed decision ahead Tuesday, 17 Jun 2014 | 4:05 PM ET
    A trader works on the floor of the New York Mercantile Exchange.

    Stocks fluctuated on Tuesday a day before the Federal Reserve's policy decision.

  • Midday movers: Allergan, Coca-Cola, Netflix & More Tuesday, 17 Jun 2014 | 12:12 PM ET

    Some of Tuesday's midday movers:

  • Early movers: T, AMZN, AAPL, TSLA & more Tuesday, 17 Jun 2014 | 7:38 AM ET
    Traders work the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • June 16- Edwards Lifesciences Corp said on Monday that U.S. health regulators approved its next generation heart valve replacement system for high risk patients and those deemed too frail to endure open heart surgery.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • June 12- Medtronic Inc said on Thursday its minimally invasive heart valve replacement system received U.S. approval to treat patients deemed at high risk for surgery, expanding the eligible patient population for its CoreValve device.

  • May 20- Medtronic Inc agreed to pay more than $1 billion to rival Edwards Lifesciences Corp to settle patent litigation and keep its CoreValve artificial heart valve on the U.S. market. Edwards was first to market with its Sapien technology in 2011 in the United States, while Medtronic received U.S. regulatory approval for CoreValve in January.

  • Midday movers: General Motors, Caterpillar & More Tuesday, 20 May 2014 | 1:01 PM ET

    Some of Tuesday's midday movers:

  • May 20- Medtronic Inc agreed to pay royalties to rival Edwards Lifesciences Corp so it can continue to sell its CoreValve replacement heart valves, the medical device maker said on Tuesday. Medtronic said it would give Edwards a one-time payment of $750 million, plus ongoing royalty payments through April 2022, based on a percentage of CoreValve sales.

  • May 20- Medtronic Inc said on Tuesday it agreed to pay royalties to rival medical device maker Edwards Lifesciences Corp in a settlement that allows Medtronic to continue to sell its CoreValve replacement heart valves.

  • Midday movers: Twitter, General Motors, Visa & More Monday, 14 Apr 2014 | 1:04 PM ET
    The Twitter banner hangs at the NYSE.

    Some of Monday midday movers:

  • Early movers: C, MSFT, JNJ, LLY, V & more Monday, 14 Apr 2014 | 9:07 AM ET
    Traders on the floor of the New York Stock Exchange.

    These are the companies making headlines before the bell.

  • Medical appliance stocks: Analyst shares her picks Friday, 4 Apr 2014 | 12:46 PM ET
    An Edwards Lifesciences Corp. SAPIEN transcatheter heart valve is assembled in a training room at company headquarters in Irvine, Calif.

    Shagun Chadha shares her top pick among medical appliance companies and gives other sector names she likes as well.